40 Participants Needed

Cognitive Training for Mild Cognitive Impairment

Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Nova Scotia Health Authority
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Cognitive training, Cognitive therapy, Cognitive behavioral training, Neurocognitive training for Mild Cognitive Impairment?

Research suggests that cognitive training can help improve thinking skills and delay further decline in older adults with mild cognitive impairment. Some studies have shown benefits in both cognitive and social functions, although the certainty of these findings is still being explored.12345

Is cognitive training safe for humans?

Research suggests that cognitive training is generally safe for older adults, including those with mild cognitive impairment or dementia.12678

How is cognitive training different from other treatments for mild cognitive impairment?

Cognitive training is unique because it uses specific mental exercises to improve brain function and delay cognitive decline, leveraging the brain's ability to adapt and change (neuroplasticity). Unlike medications, which have not been very successful for mild cognitive impairment, cognitive training focuses on enhancing memory and cognitive skills through targeted activities, often using computer programs.1891011

Research Team

KA

Karen A Chipman, PhD

Principal Investigator

Nova Scotia Health Authority

Eligibility Criteria

This trial is for seniors with a clinical diagnosis of Mild Cognitive Impairment. It's designed to help those who struggle with everyday memory problems and may also have mild mood-related symptoms.

Inclusion Criteria

I have been diagnosed with Mild Cognitive Impairment.

Exclusion Criteria

I have a neurological condition that affects my thinking.
I have been diagnosed with dementia.
History of alcohol or drug abuse
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Cognitive Training

Participants undergo cognitive training focusing on everyday memory problems and problem-solving approaches

8 months
Regular group sessions

Follow-up

Participants are monitored for changes in mood, caregiver burden, memory testing, and quality of life

3 months
Assessments at months 3, 5, and 8

Treatment Details

Interventions

  • Cognitive training
Trial Overview The study tests a cognitive training program focused on improving daily memory issues in seniors with Mild Cognitive Impairment. The program includes traditional memory exercises and problem-solving techniques.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive trainingExperimental Treatment1 Intervention
Group II: No cognitive trainingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nova Scotia Health Authority

Lead Sponsor

Trials
302
Recruited
95,300+

Karen Chipman

Lead Sponsor

Trials
1
Recruited
40+

Nova Scotia Health Research Foundation

Collaborator

Trials
15
Recruited
34,100+

Findings from Research

The MEMO+ study is a randomized controlled trial involving 162 participants with mild cognitive impairment (MCI) to evaluate the efficacy of cognitive training and psychosocial interventions over an eight-week period.
The study aims to measure both immediate and long-term effects on cognitive function and daily living skills, potentially leading to improved well-being for individuals with MCI.
Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study.Bier, N., Grenier, S., Brodeur, C., et al.[2022]
Cognitive Training (CT) in patients with Mild Cognitive Impairment (MCI) and early Alzheimer's Disease (AD) showed variable effects on brain structure and function, with some studies indicating increased cortical thickness and grey matter volumes, but no changes in hippocampal volumes.
The review included 19 studies, highlighting significant heterogeneity and variable quality, suggesting that while CT may lead to changes in brain activation and connectivity, more robust research is needed to clearly link these changes to clinical improvements.
Neuroimaging Outcomes in Studies of Cognitive Training in Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review.Beishon, L., Intharakham, K., Swienton, D., et al.[2021]
Cognitive training (CT) was found to be feasible and acceptable for both healthy older adults and individuals with mild cognitive impairment (MCI) or dementia, with 37 participants providing positive feedback after 12 weeks of training.
Participants reported several benefits from CT, including enjoyment and improved cognitive awareness, but also faced barriers such as technology issues and emotional challenges, particularly those with dementia, highlighting the need for tailored approaches in future implementations.
Qualitative Analysis of the Cognition and Flow (CoGFlowS) Study: An Individualized Approach to Cognitive Training for Dementia Is Needed.Beishon, L., Haunton, V., Subramaniam, H., et al.[2021]

References

Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study. [2022]
2.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Neuroimaging Outcomes in Studies of Cognitive Training in Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review. [2021]
Qualitative Analysis of the Cognition and Flow (CoGFlowS) Study: An Individualized Approach to Cognitive Training for Dementia Is Needed. [2021]
Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial. [2022]
MEMO+: Efficacy, Durability and Effect of Cognitive Training and Psychosocial Intervention in Individuals with Mild Cognitive Impairment. [2022]
Effect of cognitive training on patients with breast cancer reporting cognitive changes: a systematic review and meta-analysis. [2023]
Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. [2022]
Effectiveness of an Innovative Cognitive Treatment and Telerehabilitation on Subjects With Mild Cognitive Impairment: A Multicenter, Randomized, Active-Controlled Study. [2022]
A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. [2020]
Cognitive and memory training in adults at risk of dementia: a systematic review. [2023]
Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security